<?xml version="1.0" encoding="UTF-8"?>
<ref id="ppat.1006932.ref017">
 <label>17</label>
 <mixed-citation publication-type="journal">
  <name>
   <surname>Marzi</surname>
   <given-names>A</given-names>
  </name>, 
  <name>
   <surname>Engelmann</surname>
   <given-names>F</given-names>
  </name>, 
  <name>
   <surname>Feldmann</surname>
   <given-names>F</given-names>
  </name>, 
  <name>
   <surname>Haberthur</surname>
   <given-names>K</given-names>
  </name>, 
  <name>
   <surname>Shupert</surname>
   <given-names>WL</given-names>
  </name>, 
  <name>
   <surname>Brining</surname>
   <given-names>D</given-names>
  </name>, 
  <etal>et al</etal>
  <article-title>Antibodies are necessary for rVSV/ZEBOV-GP-mediated protection against lethal Ebola virus challenge in nonhuman primates</article-title>. 
  <source>Proc Natl Acad Sci U S A</source>. 
  <year>2013</year>;
  <volume>110</volume>(
  <issue>5</issue>):
  <fpage>1893</fpage>â€“
  <lpage>8</lpage>. 
  <comment>doi: 
   <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1073/pnas.1209591110" xmlns:xlink="http://www.w3.org/1999/xlink">10.1073/pnas.1209591110</ext-link>
  </comment> ; PubMed Central PMCID: PMCPMC3562844.
  <?supplied-pmid 23319647?>
  <pub-id pub-id-type="pmid">23319647</pub-id>
 </mixed-citation>
</ref>
